PE11.10 Using nationally representative surveillance data to understand the relationship between HIV incidence, prevalence, and prevention interventions in high HIV prevalence settingsE-posterEpidemiology of HIV
PE05.08 Using participatory action research tools to understand gender dynamics in uptake of HIV prevention measures and participation in research: insights through a road-block mapping exerciseE-posterCommunity engagement in prevention research
PE01.59 Using social maps to explore young women's experiences with social support of their oral PrEP use in Kenya and South AfricaE-posterBehavioural and social science research
PE25.05 Utilization patterns and HIV incidence within the first year of initiation of FTC/TDF for HIV pre-exposure prophylaxis (PrEP) among insured persons in the USE-posterProduct acceptability and adherence
OA13.05LB Utilizing a robust HIV prevention community engagement framework to engage communities in COVID-19 prevention effortsOral Abstract SessionCommunity engagement in prevention research
OA08.02 Vaccination induces maturation of diverse unmutated VRC01-class precursors to HIV-1 broadly neutralizing antibodies in an Ig-humanized mouse modelOral Abstract SessionBroadly neutralizing antibodies
PU20.01 Vaccination with Ad26.ZEBOV, MVA-BN-Filo or MVA-BN-Filo, Ad26.ZEBOV induced predominantly IgG binding to Ebola glycoprotein in cervico-vaginal mucus in HIV-infected and uninfected participantsPublication OnlyMucosal immunity
PE16.03 Validating HEART: a HEAlthy relationships assessment tool for PrEP useE-posterImplementation science, including structural interventions, PrEP & VMMC
PU01.14 Validating tools to screen for and monitor oral PrEP adherencePublication OnlyBehavioural and social science research
PE28.02 Variable HIV seroincidence rates in a cohort of high-risk men who have sex with men (MSM) and transgender women (TGW) in ChinaE-posterTransmission of HIV
seek-warrow-warrow-eseek-e421 - 430 of 444 items